Dark Forest Capital Management’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.08M Buy
26,089
+21,195
+433% +$4.39M 0.33% 53
2026
Q1
$1.1M Buy
+4,894
New +$1.22M 0.1% 341
2025
Q4
Sell
-3,839
Closed -$1.05M 1293
2025
Q3
$1.05M Buy
3,839
+631
+20% +$172K 0.04% 720
2025
Q2
$828K Buy
+3,208
New +$765K 0.03% 799
2025
Q1
Sell
-2,285
Closed -$523K 1404
2024
Q4
$523K Buy
2,285
+1,257
+122% +$303K 0.08% 420
2024
Q3
$251K Buy
+1,028
New +$230K 0.03% 745
2023
Q1
Sell
-125
Closed -$26K 1437
2022
Q4
$26K Sell
125
-924
-88% -$203K 0.01% 522
2022
Q3
$229K Buy
1,049
+1,047
+52,350% +$238K 0.04% 369
2022
Q2
$0 Sell
2
-222
-99% -$47.3K ﹤0.01% 1303
2022
Q1
$54K Buy
224
+63
+39% +$15.2K 0.01% 599
2021
Q4
$42K Sell
161
-123
-43% -$31.9K 0.02% 480
2021
Q3
$75K Buy
+284
New +$77.7K 0.03% 465

Other funds holding RMD

Dark Forest Capital Management's RMD Position: Q2 2026 in Review

Dark Forest Capital Management increased its ResMed (RMD) stake by 433% in Q2 2026, buying an estimated $4.39M and bringing the position to 26,089 shares worth $5.08M. The position accounts for 0.33% of the portfolio, ranked #53.

Dark Forest Capital Management first reported a position in RMD in Q3 2021 and has held it in 12 quarters since. 880 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Dark Forest Capital Management held 26,089 shares of ResMed worth $5.08M as of Q2 2026.
  • Dark Forest Capital Management bought 21,195 ResMed shares in Q2 2026, an estimated $4.39M.
  • ResMed made up 0.33% of Dark Forest Capital Management's portfolio in Q2 2026, its #53 holding.
  • Dark Forest Capital Management first reported a position in ResMed in Q3 2021 and has held it in 12 quarters since.
  • 880 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Dark Forest Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.